Mutant p53 and ETS2, a tale of reciprocity
TP53 is one of the most frequently inactivated tumor suppressor genes in human cancer. However, unlike other tumor suppressor genes whose expression is lost, TP53 is usually inactivated as a result of a single nucleotide change within the coding region. Typically, these single nucleotide mutations...
Main Author: | Luis Alfonso Martinez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00035/full |
Similar Items
-
Immunohistochemistry Assessment of P53 Protein in Basal Cell Carcinoma
by: Reza Ghaderi Fatemeh Haghighi
Published: (2005-12-01) -
Comparing mutant p53 and a wild-type p53 isoform, p47 : rationale for the selection of mutant p53 in tumours
by: Marini, Wanda.
Published: (2009) -
Mutant p53 as an Antigen in Cancer Immunotherapy
by: Navid Sobhani, et al.
Published: (2020-06-01) -
p63 and p53: Collaborative Partners or Dueling Rivals?
by: Dana L. Woodstock, et al.
Published: (2021-07-01) -
Recent Synthetic Approaches towards Small Molecule Reactivators of p53
by: Jerson L. Silva, et al.
Published: (2020-04-01)